Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-06-10 @ 6:58 AM
Study NCT ID:
NCT02982395
Status:
TERMINATED
Last Update Posted:
2019-08-30
First Post:
2016-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC
Sponsor:
Samyang Biopharmaceuticals Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DPMBLC301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None